教員業績データベース |
|
論文種別 | 原著 |
言語種別 | 英語 |
査読の有無 | 査読あり |
表題 | Relationship between YKL-40 and Pulmonary Arterial Hypertension in Systemic Sclerosis. |
掲載誌名 | 正式名:Modern rheumatology 略 称:Mod Rheumatol ISSNコード:1439-7609(Electronic)1439-7595(Linking) |
巻・号・頁 | 29,pp.476-483 |
著者・共著者 | Furukawa Tetsuya, Matsui Kiyoshi, Kitano Masayasu, Yokoyama Yuichi, Sekiguchi Masahiro, Azuma Naoto, Imai Yasutomo, Hirota Seiichi, Yamanishi Kiyofumi, Sano Hajime |
発行年月 | 2019/05 |
概要 | OBJECTIVES:Systemic sclerosis (SSc) is an intractable connective tissue disease that causes skin and organ fibrosis. Interstitial lung disease (ILD) and pulmonary arterial hypertension (PAH) affect its prognosis. YKL-40 protein impacts inflammation and tissue remodeling. Therefore, we evaluated the utility of YKL-40 blood levels in identifying patients with SSc complicated by PAH, as confirmed by immunohistochemistry (IHC) examination.METHODS:We retrospectively analyzed 78 patients with SSc and performed IHC oAge-adjusted YKL-40 serum levels were analyzed.RESULTS:YKL-40 age percentile was significantly elevated in SSc patients. There was no difference between patients with SSc with and without ILD and PAH. YKL-40 age percentile was greater in patients with PAH complication. YKL-40 immunostaining was negative in normal skin and prominent in the subcutaneous vascular wall of all SSc samples. Re |
DOI | 10.1080/14397595.2018.1480256 |
PMID | 29788800 |